These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
70 related articles for article (PubMed ID: 14716911)
1. [Focus on smoking cessation or drugs?]. Lindberg M Ugeskr Laeger; 2003 Dec; 165(50):4872; author reply 4872-3. PubMed ID: 14716911 [No Abstract] [Full Text] [Related]
2. [Focus on smoking cessation or drugs--2]. Lindberg M Ugeskr Laeger; 2004 Jan; 166(3):178-9; author reply 179. PubMed ID: 14870652 [No Abstract] [Full Text] [Related]
3. Spending decisions for tobacco-related disease treatment and tobacco control: an example and a solution. Thomson G; Wilson N N Z Med J; 2005 Feb; 118(1210):U1337. PubMed ID: 15776107 [No Abstract] [Full Text] [Related]
4. A cost-effectiveness analysis of a community pharmacist-based smoking cessation programme in Thailand. Thavorn K; Chaiyakunapruk N Tob Control; 2008 Jun; 17(3):177-82. PubMed ID: 18285385 [TBL] [Abstract][Full Text] [Related]
5. [Introduction to asthma and chronic obstructive pulmonary disease pharmacoeconomics]. Jahnz-Rózyk K Pol Merkur Lekarski; 2004 May; 16 Suppl 1():5-6, 8. PubMed ID: 15524004 [TBL] [Abstract][Full Text] [Related]
6. [Walk-in spirometry pilot project for discovering of early chronic obstructive pulmonary disease]. Løkke A; Christensen LB; Fuglsang C Ugeskr Laeger; 2009 Oct; 171(43):3083-8. PubMed ID: 19852895 [TBL] [Abstract][Full Text] [Related]
7. [Determining the possibility of collecting reliable data for use in decision making in health care on the example of cost-effectiveness analysis of methods used in smoking cessation]. Bała M Przegl Lek; 2004; 61(10):1180-3. PubMed ID: 15794284 [TBL] [Abstract][Full Text] [Related]
8. The cost of chronic obstructive pulmonary disease and its effects on managed care. Mapel D; Chen JC; George D; Halbert RJ Manag Care Interface; 2004 Apr; 17(4):61-6. PubMed ID: 15108761 [TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of inhaled corticosteroids for chronic obstructive pulmonary disease according to disease severity. Sin DD; Golmohammadi K; Jacobs P Am J Med; 2004 Mar; 116(5):325-31. PubMed ID: 14984818 [TBL] [Abstract][Full Text] [Related]
10. [Costs of exacerbations of chronic obstructive pulmonary disease in primary and secondary care in 2007--results of multicenter Polish study]. Jahnz-Rózyk K; Targowski T; From S Pol Merkur Lekarski; 2009 Mar; 26(153):208-14. PubMed ID: 19388534 [TBL] [Abstract][Full Text] [Related]